lifesciencelaw.ch

 

Covid-19 vaccines: authorised

22. July 2022 – The European Medicines Agency (EMA) started evaluating the renewal of the conditional marketing authorisation for Spikevax. Spikevax (previously Covid-19 vaccine Moderna) is a vaccine for preventing Covid-19 disease in people aged six years and older.

For more information, see here.